Compounds > gemcitabine

Page last updated: 2024-08-24

gemcitabine and ganciclovir

gemcitabine has been researched along with ganciclovir in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (38.46)	29.6817
2010's	6 (46.15)	24.3611
2020's	2 (15.38)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Andrei, G; De Jonghe, S; Groaz, E; Herdewijn, P; Snoeck, R; Zheng, Z	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Delecluse, HJ; Feng, WH; Hong, G; Kenney, SC	1
Boucher, PD; Shewach, DS	1
Chen, Y; Kong, D; Liu, R; Wang, G; Xu, Y; Yang, K; Zhang, Z; Zhao, W	1
Chang, KP; Chang, YS; Fan, HC; Hsieh, CH; Hsu, CL; Huang, Y; Huang, YC; Kuo, YC; Lee, LY; Li, HP; Lin, AC; Lin, TL; Lui, KW; Wang, HM	1
Ambinder, RF; Chen, J; Choi, TH; Chong, CR; Dong, SM; Hayward, SD; Kim, EJ; Kim, H; Lee, HG; Lee, JM; Liu, JO; Park, JH; Park, PG	1
Allorge, D; Barthelemy, C; Bonnabry, P; Décaudin, B; Humbert, L; Lebecque, M; Odou, P; Pinturaud, M; Richeval, C; Sidikou, O; Simon, N; Soichot, M; Vasseur, M	1
de Greeuw, I; Eersels, JLH; Greijer, AE; Middeldorp, JM; Molthoff, CFM; Novalić, Z; Verkuijlen, SAWM; Verlaan, M	1

Reviews

1 review(s) available for gemcitabine and ganciclovir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

12 other study(ies) available for gemcitabine and ganciclovir

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Influence of 4'-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2. ACS medicinal chemistry letters, 2021, Jan-14, Volume: 12, Issue:1 Topics:	2021
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. Journal of virology, 2004, Volume: 78, Issue:4 Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; B-Lymphocytes; Cell Line, Transformed; Deoxycytidine; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; Gemcitabine; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Mice; Mice, SCID; Signal Transduction; Tumor Cells, Cultured; Virus Activation	2004
In vitro and in vivo enhancement of ganciclovir-mediated bystander cytotoxicity with gemcitabine. Molecular therapy : the journal of the American Society of Gene Therapy, 2005, Volume: 12, Issue:6 Topics: Animals; Antiviral Agents; Cell Line; Cell Line, Tumor; Deoxycytidine; DNA; Drug Synergism; Female; Ganciclovir; Gemcitabine; Genetic Therapy; Humans; In Vitro Techniques; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Simplexvirus; Thymidine Kinase	2005
Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer. Molecular carcinogenesis, 2013, Volume: 52, Issue:3 Topics: Animals; Apoptosis; Bystander Effect; Connexin 43; Dendrimers; Deoxycytidine; Ganciclovir; Gemcitabine; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Lipids; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Polyamines; Promoter Regions, Genetic; Prostatic Neoplasms; Simplexvirus; Thymidine Kinase; Transfection; Xenograft Model Antitumor Assays	2013
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma. Oncotarget, 2015, Oct-13, Volume: 6, Issue:31 Topics: Animals; Anticonvulsants; Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Carcinoma; Cell Proliferation; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; Gemcitabine; Gene Expression Profiling; Herpesvirus 4, Human; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Inbred NOD; Mice, SCID; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Oncolytic Virotherapy; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Valproic Acid; Viral Load; Virus Activation; Xenograft Model Antitumor Assays	2015
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation. Oncotarget, 2015, Oct-13, Volume: 6, Issue:31 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Drug Repositioning; Enzyme Induction; Epstein-Barr Virus Infections; Female; Ganciclovir; Gemcitabine; Herpesvirus 4, Human; Humans; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Protein Kinases; RNA Interference; Signal Transduction; Stomach Neoplasms; Thymidine Kinase; Time Factors; Transfection; Tumor Burden; Viral Proteins; Virus Activation; Xenograft Model Antitumor Assays	2015
Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study. PloS one, 2016, Volume: 11, Issue:7 Topics: Antineoplastic Agents; Camptothecin; Cyclophosphamide; Cytarabine; Deoxycytidine; Drug Compounding; Drug Contamination; Fluorouracil; Ganciclovir; Gemcitabine; Humans; Ifosfamide; Irinotecan; Methotrexate; Occupational Exposure; Prospective Studies	2016
Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. Journal of medical virology, 2017, Volume: 89, Issue:12 Topics: Animals; Antiviral Agents; Carcinoma; Deoxycytidine; Disease Models, Animal; DNA, Viral; Epstein-Barr Virus Infections; Ganciclovir; Gemcitabine; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Valproic Acid; Viral Load; Virus Activation	2017